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Introduction
Although the basic concept of disease aggressiveness has 
always been used to describe several pathologies, especially 
defining cancer [1-3], a general mathematic formula associated 
to such a parameter is still lacking. The tool that comes closest 
to such an idea in human medicine is a scoring system developed 
to better define the enzymology of hepatocellular carcinoma 
[4]. Interestingly, only within the discipline of Plant Pathology 
investigators were able to develop a Composite Aggressiveness 
Index (CAI) relative to Phytophora infestans activity on potatoes 
[5]. This very index was used as a template to develop the formula 
of DAI (Disease Aggressiveness Index), as described below. Such 
a system was conceived in order to provide biostatistics of a tool 
able to both better classify diseases and integrate predictive models 
such as MuSER and E-Muser [6-8].
Methods & Results
The hereby developed Disease Aggressiveness Index (DAI) is 
based on the CAI (Composite
Aggressiveness Index) formula [5]:
(a)    CAI = IF * LS * SC / LP
in which IF: Infection Frequency, LS: Lesion Size (mm2), SC: 
Sporulation Capacity and LP: Latent Infection Period. Since such an 
equation was designed to define plant infections, all variables were 
converted to human epidemiological ones.
(b)        DAI = I * LS * P / MOA * 105
in which DAI: Disease Aggressiveness Index, I: Incidence, LS: 
Lesion Size (mm2), P: Prevalence and MOA (Mean Onset Age). 
After trying some comparative calculus, it became clear that the 
correction coefficient (i.e. 105) was necessary to make the resulting 
value comfortable and usable. The following elaboration was made 
about Multiple Sclerosis 2017 worldwide data:
(c) DAI = 0.00073 * 36 * 0.02348 / 35 = 0.00001763 (or 1.76 
* 10-5)
(d) DAI = 0.00073 * 36 * 0.02348 / 35 * 105 = 1.76
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Abstract 
Although the basic concept of disease aggressiveness has always been used to describe several pathologies, especially defining cancer, a general 
mathematic formula associated to such a parameter is still lacking. Interestingly, only within the discipline of Plant Pathology investigators were able 
to develop a Composite Aggressiveness Index (CAI) relative to Phytophora infestans activity on potatoes. This very index was used as a template to 
develop the formula of DAI (Disease Aggressiveness Index). Taking together all the above evaluations and results, it can be inferred that DAI (Disease 
Aggressiveness Index) could become a very useful tool to mathematically compare diseases and thus set economical prioritization strategies. 
Nevertheless, such an index could be very useful and supportive to act as a correction coefficient for predictive algorithms..
Table 1: Disease Aggressiveness Index (DAI) calculated for some severe diseases. LS: Lesion Size; MOA: Mean Age at Onset.
Disease Incidence LS (mm2) Prevalence MOA DAI
HIV 1942100 [9] NA 36822200 [9] 15 [10] 4.77 * 1012
Tuberculosis 1929208600 [9] 56.25 [11] 8965800 [9] All ages 9.77 * 1017
Stomach cancer 1220700 [9] 9 [12] 2823200 68 [13] 4.56 * 1011
Colon cancer 1833500 [9] 20.25 [14] 9352300 [9] 32 [15] 1.09 * 1013
Stroke 11931100 [9] 3.80 [16] 104178700 [9] 69 [17] 6.85 * 1013
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The present work also reports a computation about worldwide 
DAIs (year 2017) relative to different disease, in order to compare 
them to each other and make some evaluations (Table 1).
Conclusion
Taking together all the above evaluations and results, it can be 
inferred that DAI (Disease Aggressiveness Index) could become a 
very useful tool to mathematically compare diseases and thus set 
economical prioritization strategies. Nevertheless, such an index 
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